$ 11 Bn by 2024 Diabetic Retinopathy Market: Key Players: Allergan, Novartis, Bayer, Genentech and Regeneron Pharmaceuticals
The Diabetic Retinopathy Market is set to exceed USD 11 billion by 2024; according to a new research report by Global Market Insights. Numerous efforts made by organizations such as Canadian Diabetes Association to provide guidelines for diabetic retinopathy screening to patients suffering from diabetes will favor industry growth. Diabetic eye screening program, and other awareness campaigns arranged by government to reduce disease prevalence will further propel industry growth.
View full press release